AKT3 and Alzheimer disease: Increased serum levels of miR-485-3p and subsequent knockdown of AKT3 expression correlated with an increased inflammatory response in AD patients and a significant decrease in neuronal viability measured in vitro by MTT and cell apoptosis analyses [22].